Isolating Pathogen-Specific Human Monoclonal Antibodies (hmAbs) Using Bacterial Whole Cells as Molecular Probes. (2021)
Attributed to:
Development of a cost-effective protein-based combined glycoconjugate meningococcal-pneumococcal vaccine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/978-1-0716-0795-4_2
PubMed Identifier: 32959237
Publication URI: http://europepmc.org/abstract/MED/32959237
Type: Journal Article/Review
Volume: 2183
Parent Publication: Methods in molecular biology (Clifton, N.J.)
ISSN: 1064-3745